Book Value per Share: ABVC BioPharma, Inc. (ABVC)

Graphic logo of ABVC BioPharma (ABVC)

The complex asset structure of the Taiwanese biotech firm ABVC BioPharma (ABVC) determines its capital dynamics, where the net asset value per common share demonstrates a resilient base. The current level of 0.40 reflects the security's valuation. A niche monopoly on plant-based cancer formulas allows the company to exercise pricing power, while the licensing of ADHD and depression treatments ensures stable demand for alternative therapies.

ABVC BioPharma Inc. (ABVC): Share Book Value from 07/04/2022 to 10/26/2026

abvcpharma.com - analytical breakdowns and key metrics (ABVC)

- price and consensus price forecast:
Stock Quotes ABVC BioPharma Inc|ABVC - Price Target Chart
- market capitalization data:
Market Capitalization ABVC BioPharma, Inc.|ABVC - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share ABVC BioPharma|ABVC - Net Asset Value|Market Capitalization to Book Value Ratio abvcpharma.com|ABVC - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital ABVC BioPharma|ABVC - Long-Term Debt to Capital|Short-Term Debt to Equity ABVC BioPharma, Inc.|ABVC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio ABVC BioPharma, Inc.
Fundamental company valuation:ABVC BioPharma Inc - ABVC
Manufactured products of ABVC BioPharma, Inc.

ABVC BioPharma derives its competitive advantage from attracting unique researchers in oncology and CNS through a flexible, science-oriented culture. The dynamics of net equity per share digitize the capitalization efficiency of these intellectual resources, allowing the BVPS chart on GURU.Markets to track the actual strength of the business and the risks of frozen funds during asset write-downs.

Competitors of ABVC BioPharma (ABVC)

HLN - Accounting Value per Share|KVUE - Net Assets per Single Share|VRNA (Verona Pharma plc) - Book Value per Share|MENS (jyongbio.com) - Accounting Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Book Value per Share QNTM (Quantum BioPharma)|Book Value per Share FibroGen Inc FGEN|TELO - Book Value per Share|Rani Therapeutics (RANI) - Net Assets per Single Share|synergychc.com (SNYR) - Accounting Value per Share|Rallybio (RLYB) - Net Assets per Single Share|Book Value per Share LEXX|Accounting Value per Share Pulmatrix Inc (PULM)|Pheton Holdings Ltd (PTHL) - Accounting Value per Share|Accounting Value of a Share aptorumgroup.com (APM)|Book Value per Share Lyra Therapeutics, Inc. LYRA|Net Assets per Single Share Impact BioMedical, Inc. IBO|Book Value per Share TNFA (TNF Pharma)|YCBD: Net Assets per Share|Net Assets per Single Share PRFX|CYTO (Altamira Therapeutics Ltd.) - Net Asset Value per Share|Net Assets per Single Share Lipella Pharmaceuticals LIPO|Share Book Value optinose.com|Pieris Pharmaceuticals, Inc. (PIRS) - Book Value per Share|Accounting Value of a Share Procaps Group (PROC)|Book Value per Share PTPI (Petros)|Qilian International Corp - Book Value per Share|Net Assets per Single Share Acelyrin, Inc. (SLRN)|TFFP: Accounting Value of a Share